These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Results of alternating treatment of multiple myeloma--cytostatics VBMCP and recombinant interferon alfa-2B].
    Author: Gola A, Usnarska-Zubkiewicz L, Wołowiec D, Urbaniak-Kujda D, Kotlarek-Haus S.
    Journal: Pol Arch Med Wewn; 1993 Aug; 90(2):134-41. PubMed ID: 8247946.
    Abstract:
    In 19 patients with recently diagnosed multiple myeloma 3-week cycles of vincristine, BCNU, melphalan, cyclophosphamide and prednisone alternating with interferon were administered over 6-12 months. Results were compared with a control group of 33 myeloma patients treated exclusively with VBMCP cytostatics. In interferon treated patients objective response was more frequent (76%) and median survival time longer (above 35 months).
    [Abstract] [Full Text] [Related] [New Search]